Home › Funds › ACUTA CAPITAL PARTNERS, LLC › PRAX

ACUTA CAPITAL PARTNERS, LLC position in PRAX

PRAXIS PRECISION MEDICINES I · Health Care

ACUTA CAPITAL PARTNERS, LLC reported holding 82,796 shares of PRAX (PRAXIS PRECISION MEDICINES I) in its Q2 2026 13F filing — a position valued at US$27.7M, representing 19.32% of its reported portfolio and ranking #1 among its reported holdings. ACUTA CAPITAL PARTNERS, LLC has disclosed PRAX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)82.80K sh
Reported value held$27.72M
Portfolio Weight19.32%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ACUTA CAPITAL PARTNERS, LLC's PRAX position evolved

ACUTA CAPITAL PARTNERS, LLC first disclosed a stake in PRAX in Q3 2023 at 4,485,000 shares (US$7.7M). The position peaked in Q2 2026 at 82,796 shares, worth US$27.7M. Across 12 filings, ACUTA CAPITAL PARTNERS, LLC increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 82,796 shares valued at US$27.7M — a reduction of -2,105 shares quarter over quarter.. Notable position changes include a 93% trim in Q4 2023 (shares rose 174% over the following quarter), a 65% trim in Q3 2024 (shares rose 34% over the following quarter), a 67% increase in Q4 2025 (shares rose 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.49M $7.67M New
Q4 2023 299.64K $6.68M Reduce
Q1 2024 162.30K $9.90M Reduce
Q2 2024 164.43K $6.80M Add
Q3 2024 57.50K $3.31M Reduce
Q4 2024 67.50K $5.19M Add
Q1 2025 87.14K $3.30M Add
Q2 2025 74.09K $3.12M Reduce
Q3 2025 49.75K $2.64M Reduce
Q4 2025 83.04K $24.47M Add
Q1 2026 84.90K $27.35M Add
Q2 2026 82.80K $27.72M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PRAX and 13F data

PRAX (PRAXIS PRECISION MEDICINES I) is a Health Care company. 73 other funds we track also report a position in PRAX — the largest reported positions include Jupiter Topco LLC (US$1.15B), Janus Henderson Group (US$1.11B), PERCEPTIVE ADVISORS LLC (US$681.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PRAX

All PRAX fund holders →

FAQ

How long has ACUTA CAPITAL PARTNERS, LLC held PRAX?

ACUTA CAPITAL PARTNERS, LLC has disclosed PRAX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is ACUTA CAPITAL PARTNERS, LLC's current position in PRAX?

As of Q2 2026, ACUTA CAPITAL PARTNERS, LLC holds 82.80K shares of PRAX (PRAXIS PRECISION MEDICINES I), valued at $27.72M, representing 19.32% of its reported portfolio and ranking #1.

Has ACUTA CAPITAL PARTNERS, LLC been buying or selling PRAX?

In the latest 13F filing (Q2 2026), ACUTA CAPITAL PARTNERS, LLC reduced its position in PRAX. The position peaked in Q2 2026 at 82.80K shares.

Which other funds hold PRAX?

Other major institutional holders of PRAX include Jupiter Topco LLC, Janus Henderson Group, PERCEPTIVE ADVISORS LLC, among 73 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.